Literature DB >> 33485350

Total laparoscopic transabdominal-transdiaphragmatic approach for treating Siewert II tumors: a prospective analysis of a case series.

Wei Pang1,2, Gang Liu1, Yan Zhang1, Yun Huang1, Xinpu Yuan1, Zhanwei Zhao3, Chaojun Zhang4.   

Abstract

BACKGROUND: Although the morbidity of gastric cancer has decreased, the incidence of adenocarcinoma of the esophagogastric junction (AEG) is increasing. Furthermore, no consensus exists on which surgical approach should be applied for Siewert type II AEG. The purpose of our study was to evaluate the technical safety and feasibility of a new surgical approach.
METHODS: Sixty patients with Siewert type II AEG underwent laparoscopic total gastrectomy with the total laparoscopic transabdominal-transdiaphragmatic (TLTT) approach, which needs an incision in the diaphragm.
RESULTS: The median operative time, reconstruction time, and estimated blood loss were 214.8 ± 41.6 min, 29.40 ± 7.1 min, and 209.0 ± 110.3 ml, respectively. All of the patients had negative surgical margins.
CONCLUSION: There were no intraoperative complications or conversions to open surgery. Our surgical procedure provides a unique option for the safe application of laparoscopic lower mediastinal lymph node dissection and gastrointestinal reconstruction. TRIAL REGISTRATION: Chinese Clinical Trial Registry, ChiCTR1800014336. Registered on 31 December 2017 - Prospectively registered, http://www.chictr.org.cn/edit.aspx?pid=23111&htm=4 .

Entities:  

Keywords:  Adenocarcinoma of the esophagogastric junction (AEG); Laparoscopic total gastrectomy; Siewert II

Mesh:

Year:  2021        PMID: 33485350      PMCID: PMC7827998          DOI: 10.1186/s12957-021-02136-2

Source DB:  PubMed          Journal:  World J Surg Oncol        ISSN: 1477-7819            Impact factor:   2.754


  22 in total

1.  Laparoscopic mediastinal dissection via an open left diaphragm approach for advanced Siewert type II adenocarcinoma.

Authors:  Shuji Takiguchi; Yasuhiro Miyazaki; Naoki Shinno; Tomoki Makino; Tsuyoshi Takahashi; Yukinori Kurokawa; Makoto Yamasaki; Kiyokazu Nakajima; Hiroshi Miyata; Masaki Mori; Yuichiro Doki
Journal:  Surg Today       Date:  2015-09-15       Impact factor: 2.549

2.  Left thoracoabdominal approach versus abdominal-transhiatal approach for gastric cancer of the cardia or subcardia: a randomised controlled trial.

Authors:  Mitsuru Sasako; Takeshi Sano; Seiichiro Yamamoto; Motonori Sairenji; Kuniyoshi Arai; Taira Kinoshita; Atsushi Nashimoto; Masahiro Hiratsuka
Journal:  Lancet Oncol       Date:  2006-08       Impact factor: 41.316

3.  Side-to-side esophagojejunostomy during totally laparoscopic total gastrectomy for malignant disease: a multicenter study.

Authors:  Umberto Bracale; Ettore Marzano; Piero Nastro; Marco Barone; Diego Cuccurullo; Giorgio Cutini; Francesco Corcione; Giusto Pignata
Journal:  Surg Endosc       Date:  2010-04-16       Impact factor: 4.584

4.  Lymphadenectomy for adenocarcinoma of the gastroesophageal junction (GEJ): impact of adequate staging on outcome.

Authors:  Andrew P Barbour; Nabil P Rizk; Mithat Gonen; Laura Tang; Manjit S Bains; Valerie W Rusch; Daniel G Coit; Murray F Brennan
Journal:  Ann Surg Oncol       Date:  2006-11-08       Impact factor: 5.344

5.  Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the esophagus.

Authors:  Jan B F Hulscher; Johanna W van Sandick; Angela G E M de Boer; Bas P L Wijnhoven; Jan G P Tijssen; Paul Fockens; Peep F M Stalmeier; Fiebo J W ten Kate; Herman van Dekken; Huug Obertop; Hugo W Tilanus; J Jan B van Lanschot
Journal:  N Engl J Med       Date:  2002-11-21       Impact factor: 91.245

6.  Propensity Score-Matched Analysis Comparing Minimally Invasive Ivor Lewis Versus Minimally Invasive Mckeown Esophagectomy.

Authors:  Frans van Workum; Annelijn E Slaman; Mark I van Berge Henegouwen; Suzanne S Gisbertz; Ewout A Kouwenhoven; Marc J van Det; Frits J H van den Wildenberg; Fatih Polat; Misha D P Luyer; Grard A P Nieuwenhuijzen; Camiel Rosman
Journal:  Ann Surg       Date:  2020-01       Impact factor: 12.969

7.  Changes of Esophagogastric Junctional Adenocarcinoma and Gastroesophageal Reflux Disease Among Surgical Patients During 1988-2012: A Single-institution, High-volume Experience in China.

Authors:  Kai Liu; Kun Yang; Weihan Zhang; Xiaolong Chen; Xinzu Chen; Bo Zhang; Zhixin Chen; Jiaping Chen; Yongfan Zhao; Zongguang Zhou; Longqi Chen; Jiankun Hu
Journal:  Ann Surg       Date:  2016-01       Impact factor: 12.969

8.  Preoperative pre-albumin predicts prognosis of patients after gastrectomy for adenocarcinoma of esophagogastric junction.

Authors:  Wen-Xiu Han; Zhang-Ming Chen; Zhi-Jian Wei; A-Man Xu
Journal:  World J Surg Oncol       Date:  2016-11-03       Impact factor: 2.754

9.  Optimal treatment for Siewert type II and III adenocarcinoma of the esophagogastric junction: A retrospective cohort study with long-term follow-up.

Authors:  Kei Hosoda; Keishi Yamashita; Hiromitsu Moriya; Hiroaki Mieno; Masahiko Watanabe
Journal:  World J Gastroenterol       Date:  2017-04-21       Impact factor: 5.742

10.  Techniques and short-term outcomes for total minimally invasive Ivor Lewis esophageal resection in distal esophageal and gastroesophageal junction cancers: pooled data from six European centers.

Authors:  Jennifer Straatman; Nicole van der Wielen; Grard A P Nieuwenhuijzen; Camiel Rosman; Josep Roig; Joris J G Scheepers; Miguel A Cuesta; Misha D P Luyer; Mark I van Berge Henegouwen; Frans van Workum; Suzanne S Gisbertz; Donald L van der Peet
Journal:  Surg Endosc       Date:  2016-04-29       Impact factor: 4.584

View more
  3 in total

1.  Comparison of Efficacy Between Transabdominal and Transthoracic Surgical Approaches for Siewert Type II Adenocarcinoma of the Esophagogastric Junction: A Systematic Review and Meta-Analysis.

Authors:  Zonglin Li; Huaiwu Jiang; Jin Chen; Yifan Jiang; Yi Liu; Linxia Xu
Journal:  Front Oncol       Date:  2022-04-29       Impact factor: 5.738

2.  Advantages of McKeown minimally invasive oesophagectomy for the treatment of oesophageal cancer: propensity score matching analysis of 169 cases.

Authors:  Jun Xie; Lei Zhang; Zhen Liu; Chun-Lei Lu; Guang-Hui Xu; Man Guo; Xiao Lian; Jin-Qiang Liu; Hong-Wei Zhang; Shi-Ying Zheng
Journal:  World J Surg Oncol       Date:  2022-02-25       Impact factor: 2.754

3.  Transhiatal esophagectomy as a treatment for locally advanced adenocarcinoma of the gastroesophageal junction: postoperative and oncologic results of a single-center cohort THE for locally advanced GEJC.

Authors:  Hélène Meillat; Vincent Niziers; Christophe Zemmour; Jacques Ewald; Jean-Philippe Ratone; Slimane Dermeche; Jérôme Guiramand
Journal:  World J Surg Oncol       Date:  2022-03-06       Impact factor: 3.253

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.